Cargando…

Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT)

BACKGROUND: Study objectives were to evaluate the Multiple Sclerosis Impact Scale (MSIS-29) and explore an optimized scoring structure based on empirical post-hoc analyses of data from the Phase III ADVANCE clinical trial. METHODS: ADVANCE MSIS-29 data from six time-points were analyzed in a sample...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cleanthous, Sophie, Cano, Stefan, Kinter, Elizabeth, Marquis, Patrick, Petrillo, Jennifer, You, Xiaojun, Wakeford, Craig, Sabatella, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562349/ https://www.ncbi.nlm.nih.gov/pubmed/29104758 http://dx.doi.org/10.1177/2055217317725917

Ejemplares similares

Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)
por: Ramp, Melina, et al.
Publicado: (2009)

Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies
por: Regnault, Antoine, et al.
Publicado: (2023)

Analysis of the psychometric properties of the Multiple Sclerosis Impact Scale-29 (MSIS-29) in relapsing–remitting multiple sclerosis using classical and modern test theory
por: Bacci, ED, et al.
Publicado: (2016)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register
por: Jones, Kerina H., et al.
Publicado: (2013)

The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
por: Ernstsson, Olivia, et al.
Publicado: (2017)

Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014)

Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study
por: Poulos, Christine, et al.
Publicado: (2020)

The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials
por: Strijbis, Eva MM, et al.
Publicado: (2022)

Measurement Properties of the Health Literacy Questionnaire in the Understanding Multiple Sclerosis Massive Open Online Course Cohort: A Rasch Analysis
por: Bessing, Barnabas, et al.
Publicado: (2022)

Addressing the targeting range of the ABILHAND-56 in relapsing–remitting multiple sclerosis: A mixed methods psychometric study
por: Cleanthous, Sophie, et al.
Publicado: (2018)

A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis
por: Giovannoni, Gavin, et al.
Publicado: (2020)

Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale‐29
por: Rosti‐Otajärvi, Eija, et al.
Publicado: (2017)

The reliability and validity of the Turkish version of the multiple sclerosis impact scale-29
por: ÖZDEN, Fatih, et al.
Publicado: (2022)

The Incidence of Euphoria in Multiple Sclerosis: Artefact of Measure
por: Duncan, Amy, et al.
Publicado: (2016)

Outcome Measures in Clinical Trials for Multiple Sclerosis
por: van Munster, Caspar E. P., et al.
Publicado: (2017)

Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis
por: Pia Sormani, Maria, et al.
Publicado: (2020)

Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study
por: Strzok, Sara, et al.
Publicado: (2018)

PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE
por: Poulos, Christine, et al.
Publicado: (2018)

Impact of Depression, Fatigue, and Global Measure of Cortical Volume on Cognitive Impairment in Multiple Sclerosis
por: Nunnari, Domenica, et al.
Publicado: (2015)

Measuring student's proficiency in MOOCs: multiple attempts extensions for the Rasch model
por: Abbakumov, Dmitry, et al.
Publicado: (2018)

The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis
por: Brenton, J. Nicholas, et al.
Publicado: (2019)

Vision and vision-related outcome measures in multiple sclerosis
por: Balcer, Laura J., et al.
Publicado: (2015)

Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis
por: Motta, Caterina, et al.
Publicado: (2016)

Imaging outcome measures for progressive multiple sclerosis trials
por: Moccia, Marcello, et al.
Publicado: (2017)

Discriminative ability of quality of life measures in multiple sclerosis
por: Fiest, Kirsten M., et al.
Publicado: (2017)

Vision and Vision-Related Measures in Progressive Multiple Sclerosis
por: Backner, Yael, et al.
Publicado: (2019)

Aggressive multiple sclerosis: a matter of measurement and timing
por: Ellenberger, David, et al.
Publicado: (2020)

Outcome measures assisting treatment optimization in multiple sclerosis
por: Pardo, Gabriel, et al.
Publicado: (2021)

An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis
por: Kenyon, Katherine Hope, et al.
Publicado: (2022)

Measuring Fatigue in Multiple Sclerosis: There may be Trouble Ahead
por: Close, James, et al.
Publicado: (2023)

Measuring disability in multiple sclerosis: the WHODAS 2.0
por: Young, Carolyn A., et al.
Publicado: (2023)

Objectively Measured Physical Activity Is Associated with Brain Volumetric Measurements in Multiple Sclerosis
por: Klaren, Rachel E., et al.
Publicado: (2015)

Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D)
por: Goodwin, E., et al.
Publicado: (2019)

Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29
por: Raffel, Joel, et al.
Publicado: (2017)

Impact of Andropause on Multiple Sclerosis
por: Ysrraelit, Maria C., et al.
Publicado: (2021)

Movement measurements at home for multiple sclerosis: walking speed measured by a novel ambient measurement system
por: Smith, Victoria MJ, et al.
Publicado: (2018)

Psychometric performance of the PROMIS® depression item bank: a comparison of the 28- and 51-item versions using Rasch measurement theory
por: Cleanthous, Sophie, et al.
Publicado: (2019)

Reliable measurements of brain atrophy in individual patients with multiple sclerosis
por: Smeets, Dirk, et al.
Publicado: (2016)

Relationships between neuropsychological and antisaccade measures in multiple sclerosis patients
por: Ferreira, Marisa Borges, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0eld7ue2chhtha8hcdj1f8263t